Medtronic Korea plc.
Medtronic is the global leader in medical technology- alleviating pain, restoring health, and extending life for people with chronic conditions around the world. Medtronic develops and manufactures a wide range of products and therapies.
Booth No. D002
Exhibition Item
Resolute Onyx
Satellite Symposium
| Lunchtime Activities |
| Treating Complex SFA Lesions and Patients with Directional Atherectomy and IN.PACT DCB: Evidence and Real-World Experience |
| Organized by CVRF and Supported by Educational Grant from Medtronic Co., Ltd. |
Tuesday, April 25
12:45 PM - 1:45 PM
CTO Theater, Level 1 |
| Moderator(s): John Robert Laird, Jr., Hiroyoshi Yokoi |
| Panelist(s): Lawrence A. Garcia, Jin Hyun Joh, Sangmin Kim, Sanghoon Shin, Hoyoun Won |
|
| 12:45 PM |
Opening Remarks |
| 12:50 PM |
IN.PACT Drug-coated Balloon: Consistent Clinical Outcomes Across Patient Populations and Challenging Lesions |
| 1:00 PM |
Importance of Vessel Preparation with DCB: The US Experience of Leaving Nothing Behind |
| 1:10 PM |
IN.PACT Admiral DCB: Results from the Japan Randomized Control Trial |
| 1:20 PM |
Directional Atherectomy + DCB Combination Therapy: The Korea Experience |
| 1:30 PM |
Panel Discussion
|
| 1:40 PM |
Closing Remarks |
| Lunchtime Activities |
| Medtronic Luncheon Symposium |
| Organized by CVRF and Supported by Educational Grant from Medtronic Co., Ltd. |
Thursday, April 27
12:45 PM - 1:45 PM
Coronary Theater, Level 1 |
| Moderator(s): Eberhard Grube, Myung-Ho Jeong |
| Panelist(s): Sung Gyun Ahn, Jung Ho Heo, Byung-Hee Hwang, Jong-Young Lee, Sang-Rok Lee, Sang Wook Lim, Young-Hyo Lim, Sang-Ho Park, Yongwhi Park |
|
| 12:45 PM |
Opening Remark |
| 12:46 PM |
Introducing CoreWire Technology & Challenging Case with Onyx |
| 12:58 PM |
Irregular Protrusion: Impact of Stent Platform |
| 1:10 PM |
Medtronic Pipeline: Advancing and Addressing New Frontiers for DES |
| 1:22 PM |
Building Evidence for Treating Lower Risk Patients: Recent Updates From Evolut R Technology and Evidence |
| 1:34 PM |
Q & A
|
| 1:44 PM |
Closing Remark |
